ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.
ETFOptimize | HOME
Close Window
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LiveWorld Expands Board of Directors, Adding Healthcare & Tech Executive Carl Gustin

By: via GlobeNewswire

CAMPBELL, Calif., and NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), a leading social-first digital agency specializing in compliance, engagement and insight solutions for healthcare and pharma brands, today announced the appointment of Carl Gustin to its Board of Directors. Gustin brings broad experience in healthcare, technology, and AI-driven business transformation, positioning LiveWorld for accelerated growth and innovation in the pharmaceutical and healthcare sectors.

Gustin currently serves as Chief Strategy & Marketing Officer at SpeciCare – New Options in Cancer Care. A recognized industry leader, he has held senior marketing and business management roles across global corporations, emerging brands, and agencies, shaping market strategies that have driven substantial business growth. His tenure as Chief Marketing Officer at Kodak saw him lead the company’s digital transformation. Additionally, he played a pivotal role in launching Apple’s first PowerBook and has been honored as an Ad Age Top 50 Marketer.

“Carl’s expertise in healthcare, technology, and driving the application and integration of AI-driven business and marketing solutions makes him an invaluable addition to LiveWorld’s Board,” said Peter Friedman, Chairman and CEO of LiveWorld. “His strategic insights and leadership will strengthen our ability to expand our client portfolio, bring to market innovative AI solutions, and further establish LiveWorld as a key player in the healthcare and pharma marketing space.”

Gustin’s appointment reinforces LiveWorld’s commitment to evolving its AI-driven solutions and deepening its footprint in the healthcare industry. With over 28 years of experience in transforming customer relationships through digital engagement, LiveWorld continues to empower leading pharmaceutical and healthcare brands with innovative, compliant, and effective social media strategies.

For more information about LiveWorld and its Board of Directors, visit www.liveworld.com.

About LiveWorld:
LiveWorld is a social-first digital agency that unlocks the full potential of social media to transform customer relationships through integrated compliance, engagement, and insight solutions. We provide brand marketers with bold, strategy-driven creative that captivates audiences, along with AI-powered software, social moderation, and compliance solutions tailored for healthcare and pharma.

With over 28 years of expertise, LiveWorld delivers emotion-driven behavior change through digital campaigns with a human touch. Our clients include the number one brands in pharmaceuticals, healthcare, and financial-travel services. LiveWorld is headquartered in Campbell, California, with an additional office in New York City.

For media inquiries, please contact:
Matthew Hammer
mhammer@liveworld.com
(737) 212-9739

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2734e79a-51b1-484c-b675-ea1873bb93ce


Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.34
+0.20 (0.09%)
AAPL  267.70
+1.45 (0.54%)
AMD  205.27
-0.75 (-0.36%)
BAC  51.23
+0.23 (0.46%)
GOOG  299.40
+9.42 (3.25%)
META  593.05
+3.90 (0.66%)
MSFT  476.91
-1.52 (-0.32%)
NVDA  179.09
-1.55 (-0.86%)
ORCL  205.31
-5.38 (-2.55%)
TSLA  399.24
+4.00 (1.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.


 
IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.